Tumor Growth In Breast Cancer And Angiosarcoma Inhibited By Novel Monoclonal Antibody

[News]

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma...

More... (http://www.medicalnewstoday.com/releases/259435.php)